FDA Inspection
Lilly France S.A.S.Lilly France S.A.S. – FDA Inspection, Aug 28, 2018
Record Details
This FDA Inspection record concerns Lilly France S.A.S., with an inspection on August 28, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · f327e9ea-160b-4d12-8602-054ba10008d1
Inspection Facts
- Inspection number
- 1063854
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lilly France S.A.S.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 15, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 16, 2020 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| February 19, 2019 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| April 4, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lilly France S.A.S.
- FDA Inspection 1299456 - 2023-09-29
- FDA Inspection 1180181 - 2021-01-15
- FDA Inspection 1117961 - 2020-01-16
- FDA Inspection 1081382 - 2019-02-19
- FDA Inspection 1020863 - 2017-04-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.